产品详情
查看大图

  • 产品名称：TRAFFamilyMember-AssociatedNFKBActivator(TANK)(C-Term)Peptide

  • 产品型号：
  • 产品厂商：PromoCell
  • 产品文档：
你添加了1件商品 查看购物车
简单介绍：
TRAFFamilyMember-AssociatedNFKBActivator(TANK)(C-Term)Peptide
详情介绍：
Blocked Antibody anti-TANK antibody (TRAF Family Member-Associated NFKB Activator) (C-Term) (ABIN1003352)
Characteristics 14 amino acids near the carboxy terminus of human TANK.
Application Notes TANK peptide is used for blocking the activity of TANK antibody . It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 30 min at 37˚C.
Restrictions For Research Use only
Format Liquid
Concentration 200 µg/mL
Buffer Supplied in PBS pH 7.2 (10 mM NaH₂PO₄, 10 mM Na₂HPO₄, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice For products with volumes of 200 μl or less, we recommend gently tapping the vial on a hard surface or briefly centrifuging the vial in a tabletop centrifuge to dislodge any liquid in the container’s cap. The peptide solution should be gently mixed before use.
Storage -20 °C
Storage Comment Store at -20°C, stable for one year.
Expiry Date 12 months
Background publications Fromme, Verdine: "Base excision repair." in: Advances in protein chemistry, Vol. 69, pp. 1-41, 2004 (PubMed).

Harris, Bishop, Sheehy, Craig, Petersen-Mahrt, Watt, Neuberger, Malim: "DNA deamination mediates innate immunity to retroviral infection." in: Cell, Vol. 113, Issue 6, pp. 803-9, 2003 (PubMed).

Krokan, Otterlei, Nilsen, Kavli, Skorpen, Andersen, Skjelbred, Akbari, Aas, Slupphaug: "Properties and functions of human uracil-DNA glycosylase from the UNG gene." in: Progress in nucleic acid research and molecular biology, Vol. 68, pp. 365-86, 2001 (PubMed).

Willetts, Rey, Agostini, Navarro, Baudat, Vigne, Sire: "DNA repair enzyme uracil DNA glycosylase is specifically incorporated into human immunodeficiency virus type 1 viral particles through a Vpr-independent mechanism." in: Journal of virology, Vol. 73, Issue 2, pp. 1682-8, 1999 (PubMed).